Fundraising FoxRoivant
4 known investors
Find your way into Roivant
Sign up to see every warm intro you have to Roivant
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Roivant team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Roivant develops pharmaceutical medicines and medical technologies through a subsidiary model called "Vants," focused on accelerating the development and commercialization of treatments for dermatology and other therapeutic areas. The company operates as a biopharmaceutical holding with multiple focused companies advancing drug candidates through clinical trials and commercial launch.
Founders & leadership
Investors · 4
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: HongShan Capital Group's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Founder mafia
8 people who came through Roivant went on to found or lead other companies.
Frequently asked questions
- What does Roivant do?
- Roivant develops pharmaceutical medicines and medical technologies through a subsidiary model called "Vants," focused on accelerating the development and commercialization of treatments for dermatology and other therapeutic areas. The company operates as a biopharmaceutical holding with multiple focused companies advancing drug candidates through clinical trials and commercial launch.
- Who founded Roivant?
- Roivant was founded by Vivek Ramaswamy.
- Who are Roivant's investors?
- Roivant's investors include Commonweal Ventures, HongShan Capital Group, SoftBank Vision Fund, Viking Global.